Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

J&J Risperdal Off-Label Settlement Includes Exec Pay Recoupment Provision

Nov 05 2013

• By Brenda Sandburg

Related Content

Par’s Off-Label Plea Deal Includes Clawback For Execs’ Pay In Case Of Future Misconduct

Mar 06 2013

Risperdal Marketing Settlement Prevents Reprint Distribution Without sNDA

Aug 31 2012

GSK’s DoJ Settlement Requires Execs To Forfeit Bonuses If Misconduct Occurs

Jul 02 2012

Topamax "Doctor For A Day" Program Drove Off-Label Settlement

Apr 30 2010

Related Companies

Johnson & Johnson

GSK plc

Par Pharmaceutical Companies Inc.

Johnson & Johnson

Omnicare Inc.

Pfizer Inc.

Johnson & Johnson

Johnson & Johnson

Additional Topics

United States Legal Issues BioPharmaceutical

More from United States

More from North America

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window